Barotrauma
10
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Barotrauma in Hyperbaric Oxygen Therapy
Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS
Diagnostic Precision and Accuracy Using the Teed Scoring System Versus the O'Neill Grading System
"Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"
Barotrauma in Adults With Critical COVID-19
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Risk Factors for Barotrauma in COVID-19
Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA
The Ornge Comparison of Tracheal Occlusion Pressures to Ensure Safety Trial